We have proposed a dynamic model of HER2-positive mammary tumors that tends to spontaneously lose HER2 expression and progress towards a more aggressive phenotype via the acquisition of EMT and stemness properties, which are distinctive traits of claudin-low tumors. The gene discussed is ERBB2; the disease is breast cancer.